How to acquire a Country licence

There are some important steps to follow before acquiring a licence to use the AR-DRG classification system. The information below highlights the steps required and provides some useful tips.

Evaluating the classification system

Before making a decision about purchasing a licence, interested countries can trial the classification system for a period of up to six months free of charge. If a country chooses to trial the AR-DRG classification system before purchase, it is required to enter into a Deed of Confidentiality with IHPA. This Deed identifies the edition and the version of the classification system to be evaluated, and details the terms and conditions for its use.

IHPA recommends that any interested countries trial the classification system before seeking to purchase a full licence agreement.

Relevant Forms

Country licence

Countries wishing to use the System are required to enter into a licence agreement with IHPA. The licence agreement provides a country with rights to implement the System within its territory without modification, or use it as a base to develop its own local system.

Upon receipt of a formal request from a government wishing to purchase the System, IHPA will review the requirements and provide a licence agreement for the country’s appraisal and acceptance. This licence agreement includes the terms and conditions for the use of the classification system, such as the licence period and conditions for permitted third parties.

Once a licence agreement has been successfully signed and executed and payment has been received, materials required to access the   System such as grouper software, training and user documentation can be purchased.

A list of countries currently with a Licence Agreement or a Deed of Confidentiality for the AR-DRG Classification System.

Table 1: Countries currently with a Licence Agreement for the AR-DRG

Country

AR-DRG Version

ICD-10-AM-Edition

Purchased Right

Expiry Date

Commercial Authorisation Required* Y/N

Bahrain

Version 8.0

9th Edition

Use Only

Indefinite

Y

Bosnia & Herzegovina

Version 5.2

5th Edition

Develop

Indefinite

N

Bulgaria

Version 6.0

7th Edition

Develop

Indefinite

N

Ireland

Version 8.0

8th Edition

Use Only

Indefinite

Y

Lithuania

Version 8.0

9th Edition

Use Only

Indefinite

N

Macedonia

Version 5.2

5th Edition

Develop

Indefinite

Y

Moldova

Version 6.0

7th Edition

Use Only

Indefinite

N

New Zealand

Version 7.0

8th Edition

Use Only

Indefinite

N

Montenegro

Version 6.0

7th Edition

Develop

Indefinite

N

Qatar

Version 6.0

7th Edition

Develop

Indefinite

Y

Saudi Arabia

Version 6.0

6th Edition

Use Only

Indefinite

Y

Serbia

Version 6.0

6th Edition

Use Only

Indefinite

N

Singapore

Version 6.0

6th Edition

Develop

Indefinite

Y

Slovenia

Version 6.0

6th Edition

Use Only

Indefinite

N

Turkey

Version 6.0

7th Edition

Develop

Indefinite

N

 

 

Table 2: Countries currently evaluating the AR-DRG

Country

AR-DRG Version

ICD-10-AM-Edition

Purchased Right

Expiry Date

Ukraine

Version 7.0

8th Edition

Evaluation

22/07/2017

Georgia

Version 8.0

9th Edition

Evaluation

01/08/2017

Iran Version 9.0 10th Edition Evaluation 31/1/2018

 

Table 3: Countries previously licensed for the AR-DRG

Country

AR-DRG Version

ICD-10-AM-Edition

Purchased Right

Expired Date

Costa Rica

Version 4.2

 

 

02/02/2004

Croatia

Version 5.2

5th Edition

Develop

19/06/2012

Czech Republic

Version 6.0

6th Edition

Evaluation

18/09/2010

Denmark

Toolkit

 

 

01/01/2001

Fiji

 

3rd Edition

Develop

23/02/2011

Germany

Version 4.1

1st Edition

Develop

02/11/2005

Hungary

Version 7.0

8th Edition

Evaluation

25/09/2014

Malaysia

Version 5.0

3rd Edition

Evaluation

31/08/2003

Philippines

Version 6.0

7th Edition

Evaluation

13/02/2013

Romania

Version 5.0

3rd Edition

Develop

29/07/2010

Samoa

 

3rd Edition

Develop

23/02/2011

Solomon Islands

 

3rd Edition

Develop

23/02/2011

South Africa

Version 5.2

5th Edition

Evaluation

19/01/2008

Switzerland

Version 4.1

4th Edition

Evaluation

31/12/2006

Tonga

 

3rd Edition

Develop

23/02/2011

United Kingdom

Version 6.0

6th Edition

Evaluation

09/02/2010

* Please be aware that if a country requires commercial authorisation, all individuals and organisations who seek to implement software products within the country must seek approval from the country’s regulatory body.

If your country is listed as N, but your organisation requires authorisation prior to operation or commercialisation within your territories, please contact the classification licensing mailbox at classification.licensing [at] ihpa.gov.au for assistance in seeking this authorisation.

Contact us

Should you wish to evaluate or purchase the System, please email the Classification.Licensing [at] ihpa.gov.au (Classification Licensing mailbox). .

As Licence Agreements and Deeds of Confidentiality are government-to-government agreements, IHPA can only enter into discussions on licensing arrangements with other governmental departments, such as a Ministry of Health, or organisations that are nominated to represent a government. If your organisation is not a governmental department,  you will require a letter of authorisation from the governmental department you are representing. This letter must authorise your organisation to act on a relevant department’s behalf.


Contact